FINWIRES · TerminalLIVE
FINWIRES

Spyre Therapeutics Insider Sold Shares Worth $1,307,000, According to a Recent SEC Filing

By

Scott L Burrows, Chief Financial Officer, on June 25, 2026, sold 15,000 shares in Spyre Therapeutics (SYRE) for $1,307,000. Following the Form 4 filing with the SEC, Burrows has control over a total of 97,994 common shares of the company, with 97,994 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1636282/000185332726000008/xslF345X05/wk-form4_1782523902.xml

Related Articles